StonvexLoading…
StonvexStonvexStonvexCore line items from AGIG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $132.97K | $410.63K | $225.68K | $212.90K |
Operating Income | $-5.14M | $-28.75M | $-22.81M | $-2.88M |
Net Income | $-5.23M | $-29.45M | $-22.52M | $-2.83M |
EPS (Diluted) | $-0.13 | $-0.90 | $-0.66 | $-1.81 |
Total Assets | $45.63M | $31.86M | $28.83M | $8.72M |
Total Liabilities | $10.29M | $12.84M | $12.54M | $304.60K |
Cash & Equivalents | $16.20M | $4.62M | $1.51M | $6.95M |
Free Cash Flow OCF − CapEx | $-5.43M | $-16.71M | Not available | Not available |
Shares Outstanding | 44.02M | 36.92M | 34.22M | 1.91M |